Valuation: Strides Pharma Science Limited

Market Cap 97.69B 1.03B 921M 856M 778M 1.46B 1.49B 10.28B 4.02B 50.97B 3.87B 3.79B 163B P/E 2027 *
15.6x
P/E 2028 * 11.1x
Enterprise Value 97.69B 1.03B 921M 856M 778M 1.46B 1.49B 10.28B 4.02B 50.97B 3.87B 3.79B 163B EV / Sales 2027 *
1.68x
EV / Sales 2028 * 1.41x
Free-Float
68.12%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day-2.30%
1 week-3.70%
Current month-5.37%
1 month-10.44%
3 months-1.05%
6 months+5.87%
Current year+17.72%
1 week 1,051.3
Extreme 1051.3
1,107
1 month 1,051.3
Extreme 1051.3
1,260.9
Current year 768.65
Extreme 768.65
1,260.9
1 year 768.65
Extreme 768.65
1,260.9
3 years 467
Extreme 467
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 18/05/2017
Director/Board Member 82 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.30%-3.70%+33.23%+107.74% 1.05B
+3.55%+7.01%+51.42%+105.45% 1,077B
-0.25%-1.25%+32.49%+61.48% 612B
+0.59%+4.03%+25.28%+91.54% 501B
-1.48%+1.97%+72.62%+39.59% 364B
+2.37%+7.66%+33.65%+48.87% 353B
+2.64%+6.95%+21.01%+43.85% 278B
+3.24%+6.78%+0.43%+15.71% 251B
+1.86%+6.53%+45.98%+52.77% 230B
+2.49%+6.98%+33.03%+102.67% 190B
Average +1.27%+3.66%+34.91%+66.97% 385.76B
Weighted average by Cap. +1.74%+4.12%+38.65%+71.73%

Financials

2027 *2028 *
Net sales 58.23B 615M 549M 510M 464M 873M 889M 6.13B 2.4B 30.38B 2.31B 2.26B 97.22B 69.12B 730M 651M 605M 551M 1.04B 1.05B 7.27B 2.85B 36.07B 2.74B 2.68B 115B
Net income 6.28B 66.28M 59.16M 54.98M 50.01M 94.09M 95.79M 660M 258M 3.28B 249M 243M 10.48B 8.8B 92.89M 82.91M 77.06M 70.1M 132M 134M 926M 362M 4.59B 349M 341M 14.69B
Net Debt - -
Projected Income Statement - Annual - Strides Pharma Science Limited
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
15/10/26 ₹1,059.90 -2.30% 253,392
14/10/26 ₹1,084.80 -0.98% 184,350
13/10/26 ₹1,095.50 -0.06% 304,227
12/10/26 ₹1,096.20 +1.00% 80,618
09/10/26 ₹1,085.30 -0.91% 189,136
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Strides Pharma Science Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,059.90INR
Average target price
1,338.67INR
Spread / Average Target
+26.30%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Strides Pharma Science Limited
  1. Stock Market
  2. Stocks
  3. STAR Stock